TRxADE HEALTH, Inc. (MEDS) |
| 7.59 0.33 (4.55%) 09-20 16:00 |
| Open: | 7.25 |
| High: | 7.7 |
| Low: | 7.06 |
| Volume: | 18,992 |
| Market Cap: | 13(M) |
| PE Ratio: | -0.31 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Pharmaceuticals |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 12.92 |
| Resistance 1: | 11.06 |
| Pivot price: | 10.39 |
| Support 1: | 9.92 |
| Support 2: | 9.22 |
| 52w High: | 44.56 |
| 52w Low: | 3.69 |
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
| EPS | -1.700 |
| Book Value | 19.290 |
| PEG Ratio | 0.00 |
| Gross Profit | 25.040 |
| Profit Margin (%) | -4.84 |
| Operating Margin (%) | -10.39 |
| Return on Assets (ttm) | -3.3 |
| Return on Equity (ttm) | -9.1 |
Sat, 21 Sep 2024
MEDS Price History for Trxade Health Stock - Barchart
Wed, 06 Mar 2024
TRxADE Health Stock Skyrockets: Here's Why - TradingView
Fri, 16 Feb 2024
Dykema Completes Sale of Assets for TRxADE Health, Inc. - Dykema
Wed, 04 Oct 2023
Superlatus, Newly Merged with TRxADE HEALTH, Acquires the - GlobeNewswire
Mon, 07 Aug 2023
Artemis Strategic (ARTE) to Combine with Danam Health in $200M Deal - SPACInsider
Fri, 23 Jun 2023
EAT WELL GROUP TO SELL SAPIENTIA FOR USD $10 MILLION IN NASDAQ MERGER WITH MEDS & SUPERLATUS FOODS - Newswire Canada
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |